Retinal Vasculitis Secondary to Durvalumab.

Autor: R Andrade A; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Moll-Udina A; Ophthalmology Department, Hospital Clínic de Barcelona, Instituto Clínic de Oftalmología, Barcelona, Spain., Martin R; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Cilveti E; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Subirà O; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., Disfetano L; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain., García-Arumí J; Ophthalmology Department, Vall d'Hebron, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: Case reports in ophthalmology [Case Rep Ophthalmol] 2020 May 05; Vol. 11 (2), pp. 161-166. Date of Electronic Publication: 2020 May 05 (Print Publication: 2020).

Sight-Threatening Immune Retinopathy Developing Secondary to Durvalumab Treatment of Small-Cell Lung Cancer: A Case Report.

Autor: Kim, Doah¹ (AUTHOR), Jang, Jeong Kyeong² (AUTHOR), Sung, Youngje¹ (AUTHOR)

Publikováno v: Case Reports in Ophthalmology. Jan-Dec2024, Vol. 15 Issue 1, p343-352. 10p.

Ocular Inflammation Induced by Immune Checkpoint Inhibitors.

Autor: Chaudot, Florence, Sève, Pascal, Rousseau, Antoine, Maria, Alexandre Thibault Jacques, Fournie, Pierre, Lozach, Pierre, Keraen, Jeremy, Servant, Marion, Muller, Romain, Gramont, Baptiste, Touhami, Sara, Mahmoud, Habeeb, Quintart, Pierre-Antoine, Dalle, Stéphane, Lambotte, Olivier, Kodjikian, Laurent, Jamilloux, Yvan

Publikováno v: Journal of Clinical Medicine; Sep2022, Vol. 11 Issue 17, p4993, 23p

Ocular Toxicity of Targeted Anticancer Agents.

Autor: Fortes BH; Department of Ophthalmology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA., Tailor PD; Department of Ophthalmology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA., Dalvin LA; Department of Ophthalmology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. dalvin.lauren@mayo.edu.

Publikováno v: Drugs [Drugs] 2021 May; Vol. 81 (7), pp. 771-823. Date of Electronic Publication: 2021 Mar 31.